A Randomized, Controlled Trial of Panax quinquefolius extract (CVT-E002) to Reduce Respiratory Infection in Patients with Chronic Lymphocytic Leukemia

BACKGROUND: Chronic Lymphocytic Leukemia (CLL) patients are at high risk for acute respiratory illness (ARI). OBJECTIVE: Evaluate safety/efficacy of a proprietary extract of Panax quinequefolius, CVT-E002 (Afexa Life Sciences) to reduce ARI. METHODS: Double-blind, placebo-controlled, randomized tria...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: High, Kevin P., Case, Doug, Hurd, David, Powell, Bayard, Lesser, Glenn, Falsey, Ann R., Siegel, Robert, Metzner-Sadurski, Joanna, Krauss, John C., Chinnasami, Bernard, Sanders, George, Rousey, Steven, Shaw, Edward G.
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3337952/
https://ncbi.nlm.nih.gov/pubmed/22266154
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.suponc.2011.10.005
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars